Professional Research on Elan Corp. and Delcath Systems - Keys

Professional Research on Elan Corp. and Delcath Systems - Keys to
Success in Specialized Pharmaceuticals 
JOHANNESBURG, SOUTH AFRICA -- (Marketwire) -- 08/02/10 --  
www.wallstreetequityresearch.com gives shareholders valuable insight
on drug delivery stocks Elan Corp. plc (NYSE: ELN) and Delcath
Systems Inc. (NASDAQ: DCTH). Sign up today at
www.wallstreetequityresearch.com to receive free research reports on
these equities.  
Specialized pharmaceutical companies operate in an exceptionally high
risk and tumultuous industry. The successes can be high-flying but
obstacles and hindrances can be unforeseen and devastating.  
www.wallstreetequityresearch.com is a specialized website where
investors can have specific access to free reports drug delivery
industry; traders looking for analyst opinions on Elan Corp. plc,
Delcath Systems Inc. and other companies in this industry are
welcomed to sign up for a free one year membership at
http://www.wallstreetequityresearch.com/.  
Smaller, more specialized pharmaceutical companies are less likely to
absorb losses. Ireland-based Elan Corp. Plc recently paid $206.3 to
settle a U.S government investigation into an epilepsy drug. The
company posted $68.2 million in net debt last year and this recent
settlement nearly triples that. Traders can get direct and free
access to today's full report on Elan Corp. plc by signing up at
http://wallstreetequityresearch.com/August022010ElanCorp.plc(ELN)020810.php. 
The success of drug trials is exceptionally vital for specialized
pharmaceuticals like Delcath Systems Inc. A great deal of capital
goes into research and development. The results of clinical trials
can lead to long-term ramifications for these companies. Traders can
have complimentary access to today's complete research report on
Delcath Systems Inc. by signing up at
http://wallstreetequityresearch.com/August022010DelcathSystemsInc.(DCTH)020810.p
hp. 
Balanced sales, successful drug trials and lawsuit avoidance are the
keys to stability in the specialized pharmaceutical industry these
days. Visit us at http://www.wallstreetequityresearch.com/ to
understand the catalysts and forces driving or affecting the drug
delivery industry in today's economic environment. 
About Wall Street Equity Research: 
 Wall Street Equity Research
looks to bring simplicity and highly sophisticated research to an
ever-changing investing environment. Wall Street Equity Research has
been partnering with a number of North American and Emerging
Economies analysts to bring you the best of both continents in terms
of market analysis and analytical opinions.  
Contact Person: 
Edward D. Brooks  
info@wallstreetequityresearch.com 
 
 
Press spacebar to pause and continue. Press esc to stop.